Serum Institute of India
13 May 2021
Government panel recommends 12-16 week gap between Covishield doses
A government expert panel has reportedly recommended raising the time gap between two doses of the COVID-19 vaccine Covishield to 12-16 weeks.
13 May 2021
Coronavirus vaccine production to reach 9cr doses in June: Government
The Serum Institute of India and Bharat Biotech, the two companies India has entrusted to make its coronavirus vaccines, have both submitted their productions plans for the coming four months to the Indian government.
12 May 2021
US looking to produce of J&J's COVID-19 vaccine in India
The United States is considering the production of Johnson & Johnson's COVID-19 vaccine in India along with ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, Charge d'Affaires of the US Embassy, said on Tuesday.
04 May 2021
Give priority to Maharashtra in vaccine allocation: Tope to Poonawalla
Maharashtra Health Minister Rajesh Tope on Monday urged Serum Institute of India Chief Executive Officer Adar Poonawalla to give priority to the state in providing its anti-coronavirus vaccine, Covishield, as the government was ready to purchase doses from the Pune-based company.
03 May 2021
SII given over Rs. 1,700cr for 11cr Covishield doses: Centre
The Health Ministry on Monday said that a 100 percent advance of Rs. 1732.50 crore was released to the Serum Institute of India on April 28 for 11 crore doses of Covishield vaccine during May, June, and July.
02 May 2021
Getting aggressive calls from powerful people: SII CEO Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla has revealed that his decision to fly to London when India is facing a COVID-19 second wave was largely due to the threats he had been facing.
28 Apr 2021
Covishield price reduced to Rs. 300 for states: Adar Poonawalla
Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.
27 Apr 2021
COVID-19: Government asks SII, Bharat Biotech to cut vaccine prices
The central government has asked the Serum Institute of India (SII) and Bharat Biotech to reduce the prices of their COVID-19 vaccines, PTI reported on Monday.
21 Apr 2021
SII fixes Covishield's price at Rs. 600 for private hospitals
Serum Institute of India (SII) will sell Covishield at Rs. 400 per shot to states and at Rs. 600 to private hospitals, the Pune-based vaccine manufacturer said today.
20 Apr 2021
We understand India's pharmaceutical requirements: Biden administration
The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritize domestic consumption.
09 Apr 2021
India's Serum Institute refunds South Africa for undelivered coronavirus vaccines
Pune-based Serum Institute of India (SII) has fully refunded South Africa for 500,000 undelivered doses of the coronavirus vaccine, reports PTI.
08 Apr 2021
AstraZeneca serves legal notice to Serum Institute over vaccine delays
Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.
06 Apr 2021
Covishield 90% effective if doses given 2-3 months apart: Poonawalla
The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.
27 Mar 2021
Serum CEO Poonawalla hopes to launch second vaccine by September
Serum Institute of India CEO Adar Poonawalla today said that his company hopes to launch its second coronavirus vaccine by September this year.
25 Mar 2021
Amid growing cases, India temporarily halts export of AstraZeneca's vaccine
Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.
21 Mar 2021
SII to delay shipments to Brazil, Morocco, and Saudi Arabia
The Serum Institute of India (SII) will reportedly be delaying COVID-19 vaccine supplies to Brazil, Saudi Arabia, and Morocco amid criticism that India is not vaccinating enough people at home.
04 Mar 2021
Delhi HC pulls up Centre for exporting COVID-19 vaccines
The Delhi High Court on Thursday pulled up the central government over restricted COVID-19 vaccinations in India, even as vaccine exports to other nations continue.
25 Feb 2021
COVID-19 vaccines: SII to play huge role in mass production
British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
19 Feb 2021
Madras HC notice to Centre in case over Covishield side-effects
The Madras High Court on Friday issued a notice to the central government, among others, in a case pertaining to the alleged adverse reaction to the COVID-19 vaccine Covishield.
19 Feb 2021
Sri Lanka to purchase ten million Covishield doses from India
Sri Lanka will purchase ten million doses of Oxford-AstraZeneca's Covishield vaccine from India, officials have said.
03 Feb 2021
Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study
According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.
30 Jan 2021
A year into pandemic, India's death toll drops to fourth-highest
As India's battle against coronavirus logged one year on Saturday, the nation slipped on the death toll index, going from the third to fourth position.
27 Jan 2021
Sri Lanka to procure two to three million Covishield doses
Sri Lanka will purchase two to three million doses of Oxford-AstraZeneca vaccine, Covishield, from its Indian manufacturing company Serum Institute of India during the next two days, Lalith Weeratunga, the advisor to President Gotabaya Rajapaksa, said on Wednesday.
26 Jan 2021
Diplomats, including from Pakistan and China, offered coronavirus vaccines
After starting its vaccination drive on January 16, New Delhi has offered made-in-India vaccines to diplomatic corps, including to those from Pakistan and China.
25 Jan 2021
Bangladesh receives first COVID-19 vaccine consignment from India
Bangladesh on Monday received the first consignment of the five million doses of Covishield vaccines from India under a procurement agreement, four days after New Delhi gifted two million doses of the vaccine to Dhaka.
24 Jan 2021
Coronavirus: Nearly 16 lakh vaccinated in India as pace accelerates
As the first phase of COVID-19 vaccinations is underway in India, nearly 16 lakh healthcare and frontline workers have been inoculated, government data showed.
22 Jan 2021
After SII fire, BCG, rotavirus vaccine production to be hit
Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.
22 Jan 2021
Swachh Bharat helped fight coronavirus: Modi to vaccine recipients
Prime Minister Narendra Modi on Friday said that his government's 'Swachh Bharat' cleanliness mission helped in the fight against the coronavirus.
22 Jan 2021
Antonio Guterres saddened by life loss in Serum Institute fire
UN Secretary-General Antonio Guterres is saddened by the loss of life in a fire at the Serum Institute of India (SII) facility in Pune and hopes that the incident is fully investigated, his spokesperson said on Thursday.
21 Jan 2021
Five killed in Serum Institute fire; Maharashtra government orders probe
The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.
21 Jan 2021
Pune: Fire breaks out at Serum Institute of India
On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.
19 Jan 2021
Maldives to become first foreign country to receive Covishield doses
Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.
17 Jan 2021
Co-WIN app suffers glitches on 1st day of vaccination drive
The COVID-19 Vaccine Intelligence Network (Co-WIN) platform suffered several glitches on the first day of India's vaccination drive.
17 Jan 2021
Meet India's frontline workers who received first COVID-19 vaccine shots
On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.
13 Jan 2021
Delhi Police steps up security ahead of COVID-19 vaccine roll-out
The Delhi Police has made adequate security arrangements in the city for the smooth transportation of COVID-19 vaccines when the countrywide vaccination roll-out will begin later this week, officials said on Tuesday.
13 Jan 2021
Indians won't get option to choose between Covishield and COVAXIN
The government won't allow beneficiaries to choose between two coronavirus vaccines, that were granted the emergency use approval this month, Union Health Secretary Rajesh Bhushan declared on Tuesday.
12 Jan 2021
First flight with COVID-19 vaccines lands in Delhi from Pune
The first consignment of Covishield vaccines reached Delhi from Pune on Tuesday, four days ahead of the launch of a nationwide drive against the coronavirus.
11 Jan 2021
Centre will sponsor vaccination of healthcare, frontline workers: PM Modi
In his first interaction with chief ministers of all states after India approved two vaccines, Prime Minister Narendra Modi said the federal government will sponsor the vaccination of three crore healthcare and frontline workers.
11 Jan 2021
Rs. 200 per vaccine dose: SII receives government's purchase order
The Pune-based Serum Institute of India (SII) has received the purchase order for COVID-19 vaccines from the central government, officials said on Monday.
10 Jan 2021
Delhi identifies 89 sites for COVID-19 vaccination drive: Health Minister
The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.
